23-Valent Pneumococcal Polysaccharide Vaccine Industry Research Report 2024

23-Valent Pneumococcal Polysaccharide Vaccine Industry Research Report 2024


Summary

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.
23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
According to APO Research, the global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for 23-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for 23-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for 23-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine include MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 23-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 23-Valent Pneumococcal Polysaccharide Vaccine.
The report will help the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The 23-Valent Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 23-Valent Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

MSD
Sanofipasteur
CDIBP
23-Valent Pneumococcal Polysaccharide Vaccine segment by Type

Single Dose Vial
Pre-filled Syringe
23-Valent Pneumococcal Polysaccharide Vaccine segment by Application

For Children (2-10)
For Person (10-64)
For The Old (Above or equal to 65)
23-Valent Pneumococcal Polysaccharide Vaccine Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 23-Valent Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 23-Valent Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 23-Valent Pneumococcal Polysaccharide Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 23-Valent Pneumococcal Polysaccharide Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 23-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (2019-2030)
2.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Average Price (2019-2030)
2.3 23-Valent Pneumococcal Polysaccharide Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Single Dose Vial
2.3.3 Pre-filled Syringe
2.4 23-Valent Pneumococcal Polysaccharide Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 For Children (2-10)
2.4.3 For Person (10-64)
2.4.4 For The Old (Above or equal to 65)
3 Market Competitive Landscape by Manufacturers
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) of Manufacturers (2019-2024)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application
3.8 Global Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
3.9 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 MSD
4.1.1 MSD Company Information
4.1.2 MSD Business Overview
4.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
4.1.5 MSD Recent Developments
4.2 Sanofipasteur
4.2.1 Sanofipasteur Company Information
4.2.2 Sanofipasteur Business Overview
4.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
4.2.5 Sanofipasteur Recent Developments
4.3 CDIBP
4.3.1 CDIBP Company Information
4.3.2 CDIBP Business Overview
4.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
4.3.5 CDIBP Recent Developments
5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Scenario by Region
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2019-2030
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2019-2024
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2025-2030
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2019-2030
5.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2019-2024
5.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2025-2030
5.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
5.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
5.4.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
5.5.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
5.5.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
5.7.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
5.7.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030)
6.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030) & (K Dose)
6.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2030)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
6.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2019-2030)
7 Segment by Application
7.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030)
7.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030) & (K Dose)
7.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2030)
7.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
7.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain Analysis
8.1.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
8.2 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
8.2.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers
9 Global 23-Valent Pneumococcal Polysaccharide Vaccine Analyzing Market Dynamics
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
9.4 23-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings